Skip to main content
    I

    IRIDEX Corporation (IRIX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.69
    -0.00 (-0.32%)

    Market Cap: $12.12M

    Last updated: Nov 17, 2026 at 10:43 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(22/39)
    Avg Surprise
    -38.77%

    Upcoming Estimates

    Reports Nov 17, 2026 after closePeriod ending Sep 30, 2026
    EPS Consensus-$0.04
    Range-$0.04 - -$0.04
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.02-100.0%
    60d ago-$0.02-100.0%
    30d ago-$0.02-100.0%
    7d ago-$0.02-100.0%
    Current-$0.04
    Revenue Consensus
    $12.64M
    Range$12.64M - $12.64M
    1 analysts
    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.02
    Range$0.02 - $0.02
    3 analysts
    Revenue Consensus
    $15.82M
    Range$15.20M - $16.29M
    3 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA108.81x
    Price/FCF-5.98xFCF Yield-16.73%
    Profitability
    Profit Margin-6.88%Operating Margin-5.39%
    ROE-73.20%ROIC-18.73%
    Financial Health
    Debt/Equity1.08xInterest Coverage-2.30x
    Current Ratio1.82xQuick Ratio1.08x
    Trading Statistics
    Beta0.63Avg Volume28.92K
    52-Week High$1.6552-Week Low$0.61

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 3.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 45.2, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.69
    SMA 20$0.72
    SMA 50$0.71
    SMA 200$1.00
    EMA 10$0.70
    EMA 20$0.71
    EMA 50$0.74
    EMA 200$0.91

    MACD

    Line: -0.02Signal: -0.01Hist: -0.00

    ADX

    ADX: 30.5+DI: 18.3-DI: 19.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$0.74

    Bollinger Bands

    Upper Band$0.78
    Lower Band$0.65
    %B Position1866%(Upper)
    Band Width0.29

    RSI (14-Day)

    Neutral
    45.2

    Momentum Oscillators

    Stoch %K34.7
    Stoch %D28.5
    Williams %R-70.5
    ROC (10d)-4.7%
    Momentum-0.03
    CCI (20d)-86.4
    MFI (14d)23.5

    Volatility Measures

    ATR (14d)$0.06(8.9%)
    StdDev (20d)0.03
    Hist Vol59.1%(High)

    Volume Flow

    VWAP$0.69
    OBV27.6M
    AD Line-1.6M
    CMF (20d)-0.538

    Volume Metrics

    Avg Vol (20d)28.1K
    Vol Ratio3.0x(High)
    VWMA (20d)$0.71

    Pivot Points

    R3$0.75
    R2$0.74
    R1$0.71
    Pivot Point$0.70
    S1$0.68
    S2$0.67
    S3$0.64

    Advanced Oscillators

    TSI-10.31
    Ultimate Osc32.1
    KST-41.56

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about IRIX

    Gov Obligations (TTM)
    $390,861
    Gov Obligations / Revenue
    0.7%
    Obligations YoY
    N/A
    Active Awards
    17
    New Awards (TTM)
    16
    Avg Remaining Term
    2.0 mo

    Top agency: Department of Defense at 96.8% of trailing twelve month obligations across 2 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    IRIX Valuation

    GNG's valuation label for IRIX is Undervalued. It trades at 769.2x forward earnings.

    Forward P/E
    769.2x
    EV/EBITDA
    108.8x
    P/FCF
    -6.0x
    P/B
    3.3x
    IRIX valuation multiples

    IRIX Profitability: Margins, ROIC and FCF

    IRIDEX (IRIX) has a gross margin of 36.2%, an operating margin of -5.4% and a net margin of -6.9%. It posts -18.7% ROIC and a -3.9% FCF margin.

    Gross margin
    36.2%
    Operating margin
    -5.4%
    Net margin
    -6.9%
    ROIC
    -18.7%
    ROE
    -73.2%
    FCF margin
    -3.9%
    FCF yield
    -16.7%
    IRIX financial statements

    The companies most similar to IRIDEX (IRIX) include CVRx, Lifeward and Volitionrx.

    Sector: Healthcare

    Companies most similar to IRIDEX

    IRIX Bull Case vs Bear Case

    Bear case

    • IRIX has a -6.9% net profit margin.
    • IRIX's quarterly revenue changed -7.4% year over year.

    IRIX Earnings: Beat Rate and Next Report

    IRIDEX (IRIX) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is confirmed on Nov 17, 2026.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -66.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    -$0.04
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down
    IRIX earnings history

    IRIX Earnings Date

    IRIX reports Nov 17, 2026, after the close. The date is confirmed.

    IRIX Earnings Call

    The latest IRIX earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    IRIX ETF Holders

    See insider activity

    Updated Aug 20, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About IRIX

    When does IRIX report earnings?

    IRIDEX Corporation (IRIX) is confirmed to report earnings on Nov 17, 2026.

    Does IRIX pay dividends?

    IRIDEX Corporation (IRIX) does not currently pay a regular dividend.

    What is IRIX's market cap?

    IRIDEX Corporation (IRIX) has a market capitalization of $12.12M with a current stock price of $0.69.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.